Editorial discusses associations between hippocampal transverse relaxation time and amyloid PET in aging adults, indicating potential implications for cognitive health.
Journal of Magnetic Resonance ImagingEarly View EDITORIAL Editorial for "Associations Between Hippocampal Transverse Relaxation Time and Amyloid PET in Cognitively Normal Aging Adults" This article relates to: Associations Between Hippocampal Transverse Relaxation Time and Amyloid PET in Cognitively Normal Aging Adults Yu Veronica Sui, Arjun V. Masurkar, Timothy M. Shepherd, Yang Feng, Thomas Wisniewski, Henry Rusinek, Mariana Lazar, Journal of Magnetic Resonance Imaging First Published online: August 22, 2025 Nicolau Beckmann, Corresponding Author Nicolau Beckmann [email protected] orcid.org/0000-0001-7636-9240 Diseases of Aging & Regenerative Medicine, Novartis Biomedical Research, Basel, Switzerland Correspondence: Nicolau Beckmann ([email protected])Search for more papers by this author Nicolau Beckmann, Corresponding Author Nicolau Beckmann [email protected] orcid.org/0000-0001-7636-9240 Diseases of Aging & Regenerative Medicine, Novartis Biomedical Research, Basel, Switzerland Correspondence: Nicolau Beckmann ([email protected])Search for more papers by this author First published: 29 August 2025 https://doi.org/10.1002/jmri.70104Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookxLinkedInRedditWechatBluesky No abstract is available for this article. References 1N. Boublay, R. Bouet, J. M. Dorey, et al., "Brain Volume Predicts Behavioral and Psychological Symptoms in Alzheimer's Disease," Journal of Alzheimer's Disease 73, no. 4 (2020): 1343–1353, https://doi.org/10.3233/JAD-190612. 10.3233/JAD-190612 PubMed Web of Science® Google Scholar 2C. J. Swanson, Y. Zhang, S. Dhadda, et al., "A Randomized, Double-Blind, Phase 2b Proof-Of-Concept Clinical Trial in Early Alzheimer's Disease With Lecanemab, an Anti-Aβ Protofibril Antibody," Alzheimer's Research & Therapy 13, no. 1 (2021): 80, https://doi.org/10.1186/s13195-021-00813-8. 10.1186/s13195-021-00813-8 CAS PubMed Web of Science® Google Scholar 3M. Á. Rivas-Fernández, M. Bouhrara, E. J. Canales-Rodríguez, et al., "Brain Microstructure Alterations in Subjective Cognitive Decline: A Multi-Component T2 Relaxometry Study," Brain Communications 7, no. 1 (2025): fcaf017, https://doi.org/10.1093/braincomms/fcaf017. 10.1093/braincomms/fcaf017 PubMed Web of Science® Google Scholar 4B. S. Malhi, J. Lo, M. Toto-Brocchi, A. H. Avval, Y. Ma, and J. Du, "Quantitative Magnetic Resonance Imaging in Alzheimer's Disease: A Narrative Review," Quantitative Imaging in Medicine and Surgery 15, no. 4 (2025): 3641–3664, https://doi.org/10.21037/qims-24-1602. 10.21037/qims-24-1602 PubMed Web of Science® Google Scholar 5A. P. Haley, J. Knight-Scott, K. L. Fuchs, V. I. Simnad, and C. A. Manning, "Shortening of Hippocampal Spin-Spin Relaxation Time in Probable Alzheimer's Disease: A 1H Magnetic Resonance Spectroscopy Study," Neuroscience Letters 362, no. 3 (2004): 167–170, https://doi.org/10.1016/j.neulet.2004.01.031. 10.1016/j.neulet.2004.01.031 CAS PubMed Web of Science® Google Scholar 6E. Morris, A. Chalkidou, A. Hammers, J. Peacock, J. Summers, and S. Keevil, "Diagnostic Accuracy of (18)F Amyloid PET Tracers for the Diagnosis of Alzheimer's Disease: A Systematic Review and Meta-Analysis," European Journal of Nuclear Medicine and Molecular Imaging 43, no. 2 (2016): 374–385, https://doi.org/10.1007/s00259-015-3228-x. 10.1007/s00259-015-3228-x CAS PubMed Web of Science® Google Scholar 7Y. V. Sui, A. Masurkar, T. Shepherd, et al., "Associations Between Hippocampal Transverse Relaxation Time and Amyloid PET in Cognitively Normal Aging Adults," Journal of Magnetic Resonance Imaging (2025), https://doi.org/10.1002/jmri.70097 10.1002/jmri.70097 PubMed Google Scholar 8T. Yu, E. J. Canales-Rodríguez, M. Pizzolato, et al., "Model-Informed Machine Learning for Multi-Component T(2) Relaxometry," Medical Image Analysis 69 (2021): 101940, https://doi.org/10.1016/j.media.2020.101940. 10.1016/j.media.2020.101940 PubMed Google Scholar 9M. J. Knight, B. McCann, D. Tsivos, E. Couthard, and R. A. Kauppinen, "Quantitative T1 and T2 MRI Signal Characteristics in the Human Brain: Different Patterns of MR Contrasts in Normal Ageing," Magma 29, no. 6 (2016): 833–842, https://doi.org/10.1007/s10334-016-0573-0. 10.1007/s10334-016-0573-0 CAS PubMed Google Scholar 10O. Hansson, "Biomarkers for Neurodegenerative Diseases," Nature Medicine 27, no. 6 (2021): 954–963, https://doi.org/10.1038/s41591-021-01382-x. 10.1038/s41591-021-01382-x CAS PubMed Web of Science® Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation
No takes yet. Share an insight, caveat, or question.
Nicolau Beckmann (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: